Your session is about to expire
← Back to Search
Peer Support + HIT for High Blood Pressure (PT4A Trial)
N/A
Waitlist Available
Led By Rajesh Vedanthan, MD, MPH
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients ≥ 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights
PT4A Trial Summary
This trialwill test a new intervention to improve medication adherence for hypertension control, aiming to reduce blood pressure. It will assess feasibility, adherence & implementation fidelity, and compare blood pressure between trial & control groups.
Who is the study for?
This trial is for adults over 18 with high blood pressure that isn't well-controlled (systolic ≥ 140 or diastolic ≥ 90) and are enrolled in the AMPATH CDM Program. It's not for those with acute illnesses needing immediate attention, terminal illness, or who can't consent.Check my eligibility
What is being tested?
The study tests if peer delivery of medications combined with a Health Information Technology platform improves medication adherence and blood pressure control in western Kenya. It includes pilot intervention, surveys, and compares results to a matched control group.See study design
What are the potential side effects?
Since this trial focuses on delivering existing hypertension medications through peers and technology rather than testing new drugs, it does not introduce additional side effects beyond those already associated with the participants' current hypertension treatments.
PT4A Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
PT4A Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Absolute Mean Change in Systolic Blood Pressure (SBP)
Number of Confirmed Medication Deliveries
Number of Peer Completions of HIT Form
+1 morePT4A Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients Enrolled in the AMPATH CDM ProgramExperimental Treatment2 Interventions
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,713 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,814 Previous Clinical Trials
47,290,775 Total Patients Enrolled
Rajesh Vedanthan, MD, MPHPrincipal InvestigatorNYU Langone Health
2 Previous Clinical Trials
3,490 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your blood pressure is not well controlled and is consistently higher than 140/90.You are currently taking part in the AMPATH CDM Program.I am 18 years old or older.You have a very serious illness with no cure.
Research Study Groups:
This trial has the following groups:- Group 1: Patients Enrolled in the AMPATH CDM Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger